<DOC>
	<DOC>NCT00485628</DOC>
	<brief_summary>Evaluate the safety and efficacy of atomoxetine in Japanese pediatric patients with ADHD.</brief_summary>
	<brief_title>Safety Study in Outpatient Japanese Children With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients must be 6 18 years of age Patients must meet DSMIV diagnostic criteria for ADHD Patient must be able to swallow capsules Patients must be of normal intelligence Laboratory results must show no significant abnormalities Patients who weigh less than 15 kg or more than 75 kg at study entry Patients who have a documented history of bipolar disorder or any history of psychosis Patients taking any antipsychotic medication within 26 weeks of visit 1 Patients with a severe history of allergies Patients taking methylphenidate</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>